EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 100 filers reported holding EPIZYME INC in Q3 2015. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,084,000 | +29.4% | 7,540,469 | +1.2% | 0.00% | – |
| Q1 2022 | $8,568,000 | -42.7% | 7,450,156 | +24.5% | 0.00% | – |
| Q4 2021 | $14,962,000 | -62.8% | 5,984,908 | -23.8% | 0.00% | -100.0% |
| Q3 2021 | $40,234,000 | -38.7% | 7,858,273 | -0.5% | 0.00% | -50.0% |
| Q2 2021 | $65,659,000 | -3.7% | 7,901,309 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $68,199,000 | -17.0% | 7,829,978 | +3.5% | 0.00% | 0.0% |
| Q4 2020 | $82,158,000 | -6.2% | 7,565,247 | +3.1% | 0.00% | -33.3% |
| Q3 2020 | $87,579,000 | -24.4% | 7,341,130 | +1.8% | 0.00% | -25.0% |
| Q2 2020 | $115,808,000 | +6.9% | 7,210,960 | +3.2% | 0.00% | -20.0% |
| Q1 2020 | $108,372,000 | -35.3% | 6,987,192 | +2.7% | 0.01% | -16.7% |
| Q4 2019 | $167,436,000 | +127.2% | 6,806,333 | -4.7% | 0.01% | +100.0% |
| Q3 2019 | $73,704,000 | -17.0% | 7,145,393 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $88,835,000 | +31.6% | 7,078,470 | +29.9% | 0.00% | 0.0% |
| Q1 2019 | $67,505,000 | +200.8% | 5,448,299 | +49.6% | 0.00% | +200.0% |
| Q4 2018 | $22,441,000 | -53.7% | 3,643,104 | -20.3% | 0.00% | -50.0% |
| Q3 2018 | $48,443,000 | -20.3% | 4,570,139 | +1.9% | 0.00% | -33.3% |
| Q2 2018 | $60,777,000 | -20.7% | 4,485,413 | +3.9% | 0.00% | 0.0% |
| Q1 2018 | $76,624,000 | +43.8% | 4,316,826 | +1.7% | 0.00% | +50.0% |
| Q4 2017 | $53,283,000 | -29.7% | 4,245,683 | +6.7% | 0.00% | -50.0% |
| Q3 2017 | $75,770,000 | +46.7% | 3,977,430 | +16.3% | 0.00% | +33.3% |
| Q2 2017 | $51,640,000 | -6.5% | 3,419,844 | +6.2% | 0.00% | 0.0% |
| Q1 2017 | $55,202,000 | +48.1% | 3,218,862 | +4.5% | 0.00% | +50.0% |
| Q4 2016 | $37,265,000 | +28.0% | 3,079,796 | +4.1% | 0.00% | 0.0% |
| Q3 2016 | $29,118,000 | +0.6% | 2,959,095 | +4.7% | 0.00% | 0.0% |
| Q2 2016 | $28,946,000 | -13.0% | 2,826,810 | +3.0% | 0.00% | 0.0% |
| Q1 2016 | $33,274,000 | +19.5% | 2,745,338 | +57.9% | 0.00% | 0.0% |
| Q4 2015 | $27,850,000 | -89.5% | 1,738,430 | -82.5% | 0.00% | -80.0% |
| Q3 2015 | $264,631,000 | +582.2% | 9,909,237 | +513.1% | 0.01% | +233.3% |
| Q2 2015 | $38,793,000 | +48.0% | 1,616,340 | +15.8% | 0.00% | +50.0% |
| Q1 2015 | $26,206,000 | +27.6% | 1,395,417 | +28.2% | 0.00% | +100.0% |
| Q4 2014 | $20,540,000 | -25.7% | 1,088,490 | +6.8% | 0.00% | -50.0% |
| Q3 2014 | $27,631,000 | +24.8% | 1,019,236 | +43.2% | 0.00% | 0.0% |
| Q2 2014 | $22,149,000 | +41.6% | 711,732 | +3.6% | 0.00% | +100.0% |
| Q1 2014 | $15,646,000 | +193.4% | 687,116 | +168.0% | 0.00% | – |
| Q4 2013 | $5,332,000 | -33.1% | 256,341 | +29.1% | 0.00% | -100.0% |
| Q3 2013 | $7,966,000 | +3099.2% | 198,501 | +2144.0% | 0.00% | – |
| Q2 2013 | $249,000 | – | 8,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |